RETRACTED ARTICLE: Hydralazine Promotes Central Nervous System Recovery after Spinal Cord Injury by Suppressing Oxidative Stress and Inflammation through Macrophage Regulation

Abstract

Objective

This study aims to investigate the effects of hydralazine on inflammation induced by spinal cord injury (SCI) in the central nervous system (CNS) and its mechanism in promoting the structural and functional recovery of the injured CNS.

Methods

A compressive SCI mouse model was utilized for this investigation. Immunofluorescence and quantitative real-time polymerase chain reaction were employed to examine the levels of acrolein, acrolein-induced inflammation-related factors, and macrophages at the injury site and within the CNS. Western blotting was used to evaluate the activity of the phosphoinositide 3-kinase (PI3K)/AKT pathway to study macrophage regulation. The neuropathic pain and motor function recovery were evaluated by glutamic acid decarboxylase 65/67 (GAD65/67), vesicular glutamate transporter 1 (VGLUT1), paw withdrawal response, and Basso Mouse Scale score. Nissl staining and Luxol Fast Blue (LFB) staining were performed to investigate the structural recovery of the injured CNS.

Results

Hydralazine downregulated the levels of acrolein, IL-1β, and TNF-α in the spinal cord. The downregulation of acrolein induced by hydralazine promoted the activation of the PI3K/AKT pathway, leading to M2 macrophage polarization, which protected neurons against SCI-induced inflammation. Additionally, hydralazine promoted the structural recovery of the injured spinal cord area. Mitigating inflammation and oxidative stress by hydralazine in the animal model alleviated neuropathic pain and altered neurotransmitter expression. Furthermore, hydralazine facilitated motor function recovery following SCI. Nissl staining and LFB staining indicated that hydralazine promoted the structural recovery of the injured CNS.

Conclusion

Hydralazine, an acrolein scavenger, significantly mitigated SCI-induced inflammation and oxidative stress in vivo, modulated macrophage activation, and consequently promoted the structural and functional recovery of the injured CNS.

Keywords

spinal cord injury / proinflammation / oxidative stress / macrophage / acrolein scavenger

References

[1] CuiM, MaX, SunJ, et al.. Effects of STAT3 inhibitors on neural functional recovery after spinal cord injury in rats. Biosci Trends, 2017, 10(6): 460-466

[2] SternerRC, SternerRM. Immune response following traumatic spinal cord injury: Pathophysiology and therapies. Front in Immunol, 2022, 13: 1084101

[3] AllisonDJ, DitorDS. The common inflammatory etiology of depression and cognitive impairment: a therapeutic target. J Neuroinflammation, 2014, 11: 151

[4] DaviesAL, HayesKC, DekabanGA. Clinical correlates of elevated serum concentrations of cytokines and autoantibodies in patients with spinal cord injury. Arch Phys Med Rehabil, 2007, 88(11): 1384-1393

[5] GibsonAE, BuchholzAC, Martin GinisKA. C-Reactive protein in adults with chronic spinal cord injury: increased chronic inflammation in tetraplegia vs paraplegia. Spinal Cord, 2008, 46(9): 616-621

[6] AmbrozaitisKV, KontautasE, SpakauskasB, et al.. Pathophysiology of acute spinal cord injury. Medicina (Kaunas), 2006, 42(3): 255-261

[7] HallED. Antioxidant therapies for acute spinal cord injury. Neurotherapeutics, 2011, 8(2): 152-167

[8] BraughlerJM, HallED. Central nervous system trauma and stroke. I. Biochemical considerations for oxygen radical formation and lipid peroxidation. Free Radic Biol Med, 1989, 6(3): 289-301

[9] JuurlinkBH, PatersonPG. Review of oxidative stress in brain and spinal cord injury: suggestions for pharmacological and nutritional management strategies. J Spinal Cord Med, 1998, 21(4): 309-334

[10] HillRL, SinghIN, WangJA, et al.. Protective effects of phenelzine administration on synaptic and non-synaptic cortical mitochondrial function and lipid peroxidation-mediated oxidative damage following TBI in young adult male rats. Exp Neurol, 2020, 330: 113322

[11] LinY, ChenZ, TangJ, et al.. Acrolein contributes to the neuropathic pain and neuron damage after ischemic–reperfusion spinal cord injury. Neuroscience, 2018, 384: 120-130

[12] HerrSA, ShiL, GianarisT, et al.. Critical role of mitochondrial aldehyde dehydrogenase 2 in acrolein sequestering in rat spinal cord injury. Neural Regen Res, 2022, 17(7): 1505

[13] UchidaK. Current status of acrolein as a lipid peroxidation product. Trends Cardiovasc Med, 1999, 9(5): 109-113

[14] QiH, KanK, StichtC, et al.. Acrolein-inducing ferroptosis contributes to impaired peripheral neurogenesis in zebrafish. Front Neurosci, 2023, 16: 1044213

[15] BuiLC, ManaaA, XuX, et al.. Acrolein, an α, β-unsaturated aldehyde, irreversibly inhibits the acetylation of aromatic amine xenobiotics by human arylamine N-acetyltransferase 1. Drug Metab Dispos, 2013, 41(7): 1300-1305

[16] FacchinettiF, AmadeiF, GeppettiP, et al.. Alpha,beta-unsaturated aldehydes in cigarette smoke release inflammatory mediators from human macrophages. Am J Respir Cell Mol Biol, 2007, 37(5): 617-623

[17] MorettoN, FacchinettiF, SouthworthT, et al.. alpha,beta-Unsaturated aldehydes contained in cigarette smoke elicit IL-8 release in pulmonary cells through mitogen-activated protein kinases. Am J Physiol Lung Cell Mol Physiol, 2009, 296(5): L839-848

[18] HamannK, NehrtG, OuyangH, et al.. Hydralazine inhibits compression and acrolein-mediated injuries in ex vivo spinal cord. J Neurochem, 2008, 104(3): 708-718

[19] ChenZ, ParkJ, ButlerB, et al.. Mitigation of sensory and motor deficits by acrolein scavenger phenelzine in a rat model of spinal cord contusive injury. J Neurochem, 2016, 138(2): 328-338

[20] KaminskasLM, PykeSM, BurchamPC. Reactivity of hydrazinophthalazine drugs with the lipid peroxidation products acrolein and crotonaldehyde. Org Biomol Chem, 2004, 2(18): 2578-2584

[21] DueMR, ParkJ, ZhengL, et al.. Acrolein involvement in sensory and behavioral hypersensitivity following spinal cord injury in the rat. J Neurochem, 2014, 128(5): 776-786

[22] HamannK, DurkesA, OuyangH, et al.. Critical role of acrolein in secondary injury following ex vivo spinal cord trauma. J Neurochem, 2008, 107(3): 712-721

[23] MarquesSA, GarcezVF, Del BelEA, et al.. A simple, inexpensive and easily reproducible model of spinal cord injury in mice: morphological and functional assessment. J Neurosci Methods, 2009, 177(1): 183-193

[24] Liu-SnyderP, BorgensRB, ShiR. Hydralazine rescues PC12 cells from acrolein-mediated death. J Neurosci Res, 2006, 84(1): 219-227

[25] Liu-SnyderP, McNallyH, ShiR, et al.. Acrolein-mediated mechanisms of neuronal death. J Neurosci Res, 2006, 84(1): 209-218

[26] GillespieER, RuitenbergMJ. Neuroinflammation after SCI: current insights and therapeutic potential of intravenous immunoglobulin. J Neurotrauma, 2022, 39(3–4): 320-332

[27] HallED. Inhibition of lipid peroxidation in CNS trauma. J Neurotrauma, 1991, 8(Suppl1): S31-S41

[28] HallED, BraughlerJM. Free radicals in CNS injury. Res Publ Assoc Res Nerv Ment Dis, 1993, 71: 81-105

[29] SousaBC, PittAR, SpickettCM. Chemistry and analysis of HNE and other prominent carbonyl-containing lipid oxidation compounds. Free Radical Biol Med, 2017, 111: 294-308

[30] JureI, PietraneraL, De NicolaAF, et al.. Spinal Cord Injury Impairs Neurogenesis and Induces Glial Reactivity in the Hippocampus. Neurochem Res, 2017, 42(8): 2178-2190

[31] FangJ, OuQ, WuB, et al.. TcpC Inhibits M1 but Promotes M2 Macrophage Polarization via Regulation of the MAPK/NF-kappa B and Akt/STAT6 Pathways in Urinary Tract Infection. Cells, 2022, 11(17): 2674

[32] ZhouX, ChenH, HuY, et al.. Enhancer of zeste homolog 2 promotes renal fibrosis after acute kidney injury by inducing epithelial-mesenchymal transition and activation of M2 macrophage polarization. Cell Death Dis, 2023, 14(4): 253

[33] DusejaR, HeirR, LewitusGM, et al.. Astrocytic TNFα regulates the behavioral response to antidepressants. Brain Behav Immun, 2015, 44: 187-194

[34] SteruL, ChermatR, ThierryB, et al.. The tail suspension test: A new method for screening antidepressants in mice. Psychopharmacology, 1985, 85(3): 367-370